AG01CB8U

Name: 1-(3,5-Dihydroxyphenyl)-2-[2-(3-p-hydroxyphenyl)propylamino]ethanol hydrobromide
Brand: Angene Chemical
SKU: AG01CB8U

1944-12-3 | 1-(3,5-Dihydroxyphenyl)-2-[2-(3-p-hydroxyphenyl)propylamino]ethanol hydrobromide

Chemical structure of 1-(3,5-Dihydroxyphenyl)-2-[2-(3-p-hydroxyphenyl)propylamino]ethanol hydrobromide, CAS 1944-12-3

AG01CB8U

SDS

COA

Price

$0.00

Add to Cart

WARNING This product is not for human or veterinary use.

Request For Quotation

CAS Number	1944-12-3
Catalog Number	AG01CB8U(AGN-PC-0QMUR7)
Chemical Name	1-(3,5-Dihydroxyphenyl)-2-[2-(3-p-hydroxyphenyl)propylamino]ethanol hydrobromide
EC Number	217-742-8
IUPAC Name	5-[1-hydroxy-2-[1-(4-hydroxyphenyl)propan-2-ylamino]ethyl]benzene-1,3-diol;hydrobromide
InChI	InChI=1S/C17H21NO4.BrH/c1-11(6-12-2-4-14(19)5-3-12)18-10-17(22)13-7-15(20)9-16(21)8-13;/h2-5,7-9,11,17-22H,6,10H2,1H3;1H
InChI Key	SGZRQMALQBXAIQ-UHFFFAOYSA-N
MDL Number	MFCD00079288
Molecular Formula	C17H22BrNO4
Molecular Weight	384.2649
NSC Number	757811
SMILES	CC(Cc1ccc(cc1)O)NCC(c2cc(cc(c2)O)O)O.Br
Synonyms	Berotec, Berotek, Fenoterol, Fenoterol Hydrobromide, Fenoterol Hydrochloride, Hydrochloride, Fenoterol, p Hydroxyphenyl orciprenaline, p Hydroxyphenylorciprenaline, p-Hydroxyphenyl-orciprenaline, p-Hydroxyphenylorciprenaline, Partusisten, Phenoterol, Th 1165a, Th-1165a, Th1165a, Fenoterol hydrobromide, 1944-12-3, fenoterol HBr, Fenoterol (hydrobromide), Fenoterol bromide, Phenoterol hydrobromide, Partusisten, CHEBI:31601, DSSTox_CID_25419, DSSTox_RID_80867, DSSTox_GSID_45419, Fenoterol hydrobromide (JAN), Fenoterol hydrobromide [JAN], CHEMBL537445, 2-(3,5-Dihydroxyphenyl)-2-hydroxy-2'-(4-hydroxyphenyl)-1'-methyldiethylamine hydrobromide, CAS-1944-12-3, TH 1165A, EINECS 217-742-8, SR-01000075873, Fenoterol-d6, 5-(1-hydroxy-2-(1-(4-hydroxyphenyl)propan-2-ylamino)ethyl)benzene-1,3-diol hydrobromide, 5-[1-hydroxy-2-[1-(4-hydroxyphenyl)propan-2-ylamino]ethyl]benzene-1,3-diol hydrobromide, Prestwick_667, Berotec (TN), 1286129-04-1, AC1NWASK, 1-(3,5-Dihydroxy-phenyl)-2-((1-(4-hydroxybenzyl)ethyl)amino)-ethanol hydrobromide, Benzyl alcohol, 3,5-dihydroxy-alpha-(((p-hydroxy-alpha-methylphenethyl)amino)methyl)-, hydrobromide, NCGC00016721-01, MLS001056741, ARONIS24570, SCHEMBL121549, SPECTRUM1501007, DTXSID5045419, CTK8F9746, HY-B0976A, BBC/743, REGID_for_CID_5702161, SGZRQMALQBXAIQ-UHFFFAOYSA-N, HMS1568J06, HMS1921B11, Pharmakon1600-01501007, BCP28959, ZX-AS004943, Tox21_110581, Tox21_500544, BG0190, CCG-38987, MFCD00242675, NSC757811, AKOS015909691, Tox21_110581_1, API0002690, CS-5285, KS-5090, LP00544, NSC-757811, NCGC00015430-06, NCGC00093932-01, NCGC00093932-02, NCGC00093932-03, NCGC00093932-04, NCGC00261229-01, S314, SMR000326705, ACM1286129041, EU-0100544, FT-0668501, ST51015001, VU0243157-4, D01428, F 1016, C-54957, J-012593, SR-01000075873-1, SR-01000075873-6, I14-31833, Fenoterol hydrobromide, British Pharmacopoeia (BP) Reference Standard, Fenoterol hydrobromide, European Pharmacopoeia (EP) Reference Standard, 2-[3,5-Dihydroxyphenyl]-2- hydroxy-2 -[4-hydroxyphenyl]- 1 -methyldiethylamine, 5-(1-Hydroxy-2-{[1-(4-hydroxyphenyl)propan-2-yl]amino}ethyl)benzene-1,3-diol (HBr), 5-(1-hydroxy-2-{[1-(4-hydroxyphenyl)propan-2-yl]amino}ethyl)benzene-1,3-diol hydrobromide, 5-(1-hydroxy-2-{[2-(4-hydroxyphenyl)-isopropyl]amino}ethyl)benzene-1,3-diol, b romide, Fenoterol for peak identification, European Pharmacopoeia (EP) Reference Standard, 1,3-Benzenediol, 5-(1-hydroxy-2-((2-(4-hydroxyphenyl)-1-methylethyl)amino)ethyl)-, HBr (9CI), 1,3-Benzenediol,5-[1-hydroxy-2-[[2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl]-,hydrobromide, 2-(3,5-Dihydroxyphenyl)-2-hydroxy-2 inverted exclamation marka-(4-hydroxyphenyl)-1 inverted exclamation marka-methyldiethylamine hydrobromide, fenoterol, Phenoterol, Fenoterolum, Berotec, Fenoterolum [INN-Latin], C17H22BrNO4, Fenoterol [USAN:BAN:INN], Fenoterol [USAN:INN:BAN], UNII-22M9P70OQ9, C17-H21-N-O4, CID5702161, TH 1165, BRN 2157041, 13392-18-2, 1,3-Benzenediol, 5-[1-hydroxy-2-[[2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl]-, 1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane, 1-(p-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane, 3,5-Dihydroxy-alpha-(((p-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol, 3,5-dihydroxy-alpha-[[(p-hydroxy-alpha-methylphenethyl)amino]methyl]benzyl alcohol, 5-(1-Hydroxy-2-((2-(4-hydroxyphenyl)-1-methylethyl)amino)ethyl)resorcinol hydrobromide, 5-[1-Hydroxy-2-[[2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl]-1,3-benzenediol, Benzyl alcohol, 3,5-dihydroxy-.alpha.-[[(p-hydroxy-.alpha.-methylphenethyl)amino]methyl]-,

Complexity	310
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	2
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	383.073g/mol
Formal Charge	0
Heavy Atom Count	23
Hydrogen Bond Acceptor Count	5
Hydrogen Bond Donor Count	6
Isotope Atom Count	0
Molecular Weight	384.27g/mol
Monoisotopic Mass	383.073g/mol
Rotatable Bond Count	6
Topological Polar Surface Area	93A^2
Undefined Atom Stereocenter Count	2
Undefined Bond Stereocenter Count	0

Related Research Chemicals

CERTIFICATE OF ANALYSIS

Chemical Name:	Batch Number:
Chemical Structure:	CAS Registry No:
	Product ID:
	Manufacture Date:
	Storage Temperature:
	Formula:
	Molecular Weight:
	Quantity:

Analysis Data:

Test:

Result:

Conclusion: The above product meets the specifications of Angene.

Analyst:Chase

Date:

Reviewed by:Jessie

Date:

Angene International Limited

Symbol:
Hazard statements
Precautionary statements